| [1] Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update:a report from the American Heart.Association. Circulation. 2011;123(4):e18-209.
[2] 中华人民共和国卫生部.中华人民共和国卫生部中国卫生统计年鉴[C].北京:中国协和医科大学出版社, 2008:227-278.
[3] Jiang Y, Jahagirdar BN, Reinhardt RL,et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):41-49.
[4] Pittenger MF, Machay AM, Beck SC,et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.
[5] Nagaya N, kangawa K, Itoh T, et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation. 2005;112(8): 1128-1135.
[6] Dowell JD, Rubart M,Pasumarthi KB,et al. Myocyte and myogenic stem cell transplantation in the hear. Cardiovase Res. 2003;58(2):336-350.
[7] Lin J, Hu Q, Wang Z,et al. Autologous stem cell transplantation for myocardial repair. Heart Circ Physiol. 2004;287(2):H501-511.
[8] Vincentelli A, Wautot F, Juthier F, et al. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? J Thorac Cardiovasc Surg. 2003;126(6):1470-1480.
[9] Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissueengineering. Trends Biotechnol. 1998;16(5):224-230.
[10] Zimmermann WH, Melnychenko I, Eschenhagen T. Engineered heart tissue for regeneration of diseased hearts. Bomaterials. 2004;25(9):1639-1647.
[11] Matsubayashi K,Fedak PW, Mickle DA,et al. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation. 2003;108 Supp1: II219-225.
[12] Tan MY, Zhi W,Wei RQ,et al. Repair of infracted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials. 2009;30(19):3234- 3240.
[13] Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials. 2000;21: 2335-2346.
[14] Sinha VR, Bansal K, Kaushik R,et al. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm. 2004;278(1):1-23.
[15] 王宁,邢万红,李新华,等.大鼠骨髓间充质干细胞体外心肌定向诱导及心肌组织构建研究[J]. 国际生物医学工程杂志,2010,33(3): 163-167.
[16] 王振河,王挹青.骨髓间充质干细胞移植治疗心肌梗死时机再探讨[J].中华医学研究杂志,2007,7(4):327-330.
[17] 刘博武,吕安林,燕学波,等.诱导骨髓间充质干细胞分化移植后的心脏电生理特性[J].中国组织工程研究与临床康复,2011,15(32): 6072-6076.
[18] 张江兰,赵文会,王海萍.骨髓间充质干细胞向心肌细胞的分化及临床应用前景[J].河北北方学院学报(医学版),2009,26(6): 68-72.
[19] 邢玉洁.骨髓间充质干细胞诱导分化心肌细胞体内构建工程化心肌组织[D].西安:第四军医大学,2010. |